The Cellularis Discovery by Early Sight
Forecast Overview
- NAICS
- 334516
- Performance end
- 6/2026
The Cellularis Discovery by Early Sight is one of the first commercial clinical AO retinal cameras. It will be used to advance the development of new cellular imaging biomarkers for the Ophthalmic Devices Program. In particular, many new methods and tools will be developed using this system. It fulfills the FDA mission to foster clinical translation of innovative medical device technology.
Source
- Source
- HHS SBCX Forecast Export
- Source file
- Forecast.csv
- Official source
- Agency forecast source
- Last verified
- 2026-08-31
Related Federal Entities
- Department of Health and Human Services
- High-quality rotary servo based unit for IMU verification and validation testing
- High precision blood gas analyzer
- Spectroradiometer with specialized lens for characterizing head mounted displays
- Laser Vibrometer
- A spectral camera for measuring per-pixel color of an object (Minolta Specim IQ)
- Federal Technology Spending Map
- Federal Opportunity Research